Report ID: 10352559 |
Published Date: 29 Apr 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Executive Summary of the Intermittent Catheters Market (2025-2037)
1. Global Demand by Region
The global intermittent catheters market registered a valuation of USD 3.7 billion in 2024 and is projected to expand at a CAGR of 5.1% during the forecast period from 2025 to 2037 and reach a valuation worth USD 6.4 billion by 2037. Key regional insights include:
- North America: Rising cases of urinary incontinence and the presence of a well-established healthcare infrastructure bolster market expansion. The market is projected to expand at a CAGR of 4.5%, reaching USD 1.8 billion by 2037.
- Europe: With increasing awareness of self-catheterization and favorable reimbursement policies, the market is forecasted to expand at a CAGR of 4.3%. France and Germany are expected to account for over 40% of regional spending.
- Asia-Pacific: The fastest-expanding region, driven by rising healthcare investments and increasing geriatric populations in China, India, and Japan. The market is anticipated to register a CAGR of 4.8%, and reach a valuation of USD 2.6 billion by 2037.
- Latin America: Moderate expansion is expected, with Brazil leading the region due to improving healthcare access.
- Middle East & Africa: Growth is driven by the increasing adoption of advanced medical devices in the Gulf Cooperation Council (GCC) countries.
2. Rapidly Expanding Market Segments
Market Segmentation: The intermittent catheters market research report provides comprehensive industry analysis with revenue estimates and forecasts (USD Billion) from 2025 to 2037 across the following segments:
a) Hydrophilic Coated Catheters
- Projected CAGR (2025–2037): 4.7% (highest among all segments)
- Driver: Reduced risk of UTIs and higher patient comfort.
b) Female Intermittent Catheters
- Projected CAGR (2025–2037): 4.5%
- Driver: Rising awareness of women’s urological health in APAC and North America.
3. Regional Market Outlook & Payer Pricing Analysis
1. United States
- Government Spending (2024): $1.1 billion (Medicare & Medicaid cover ~60% of costs).
- Out-of-Pocket Costs: ~25% of total expenditure.
2. Europe (France, Germany, Italy, Spain)
- France & Germany: Account for ~50% of EU spending on intermittent catheters.
- Government vs. Private Spending: 80% public coverage in Germany vs. 70% in France.
3. Japan & Australia
- Japan’s NHI covers ~90% of catheter costs.
- Australia’s NDIS funds catheter access for disabled patients.
4. Nordic Countries (Sweden, Norway, Denmark)
- Fully reimbursed under public healthcare, driving high adoption rates.
Major Drivers of the Intermittent Catheter Market
- Rising Prevalence of Chronic Urological Conditions: The surging cases of chronic urological conditions drive a consistent demand for intermittent catheters. Furthermore, spinal cord injuries and neurogenic bladder dysfunction are major causes of urinary incontinence globally. Additionally, more than 25 million adults are affected by the affliction in the U.S. alone.
- Aging Population & Geriatric Care Demand: According to the World Health Organization's projections for 2030, one-sixth of the global population will have passed the age of 60, subsequently driving up catheter demand. Japan leads with 38% of its population being 65 years old and above, creating a 9% yearly increase in catheter sales. Additionally, there was a 7% growth in Medicare spending for urological devices compared to last year.
- Government Reimbursement Policies & Healthcare Spending: U.S. Medicare patients who utilize catheters obtain 80% payment coverage, while they pay the difference themselves. French and German healthcare systems provide patients with medical cost coverage ranging from 70% to 90% to reduce financial burdens on patients. The Indian Ayushman Bharat program now provides subsidies for catheters to increase patient access.
- Hydrophilic & Antimicrobial Catheters Reducing UTIs: The adoption of hydrophilic catheters has resulted in a 30% decrease in UTI risk, which subsequently expands the market share. According to the 2022 study by AHRQ, hospitals saved $1.2 billion during two years with the use of antimicrobial-coated catheters.
Intermittent Catheters Market: Key Insights
| Base Year |
2024 |
| Forecast Period |
2025-2037 |
| CAGR (2025-2037) |
5.1% |
| Base Year Market Size (2024) |
USD 3.7 billion |
| Forecast Year Market Size (2037) |
USD 6.4 billion |
| Segments Covered |
Product Type, Application, Material, End user |
| Key Companies Profiled |
Coloplast; Becton Dickinson (BD); Hollister Incorporated; ConvaTec, and others |
| Regional Scope |
|
Major Challenges of the Intermittent Catheters Market
Market entry and retention face several obstacles, including:
- Pricing Restraints: Governments commonly establish price limits on medical devices, reducing the profit margins for manufacturers. A top company collaborated with European national health organizations in 2023 to bypass price restrictions, leading to a market access improvement of 10%. Moreover, high import taxes for foreign-manufactured catheters in India lead to increased costs, making these products inaccessible to lower-income groups.
- Regulatory Hurdles: The strict pharmaceutical and medical device regulations of Japan's PMD Act caused a six-month delay in product approvals during 2022, affecting market entry. Additionally, the extensive documentation requirements for Medicare and Medicaid coverage in the USA slow the adoption of innovative catheter technologies.
Market Opportunities & Trends
1. Historical Patient Growth (2010–2020)
The number of intermittent catheter users has surged globally due to aging populations, rising urological disorders, and improved diagnosis rates.
|
Country |
Patients (2010) |
Patients (2020) |
Growth Rate |
Key Driver |
|---|---|---|---|---|
|
USA |
4.2 million |
6.8 million |
62% |
Medicare expansion, spinal injury rehab (CDC, 2021) |
|
Germany |
1.5 million |
2.4 million |
60% |
Aging population, strong reimbursement (Eurostat, 2021) |
|
France |
1.2 million |
1.9 million |
58% |
UI awareness campaigns (Haute Autorité de Santé, 2021) |
|
Spain |
0.8 million |
1.3 million |
63% |
Public healthcare coverage (WHO, 2021) |
|
Australia |
0.5 million |
0.9 million |
80% |
NDIS funding for disabilities (AIHW, 2021) |
|
Japan |
2.1 million |
3.5 million |
67% |
Super-aging society (MHLW, 2021) |
|
India |
1.0 million |
2.7 million |
170% |
Rising diabetes-linked urological issues (NHP, 2021) |
|
China |
3.0 million |
6.2 million |
107% |
Urbanization, healthcare access (NHC, 2021) |
2. Revenue Opportunities for Manufacturers
- USA: Coloplast and similar manufacturers have used Medicare policies to reach new market segments. Coloplast implemented product innovation strategies in 2023 to boost their market share by 15%, and this resulted in $200 million in increased revenue.
- India: Through collaborations with local healthcare providers in programs such as Ayushman Bharat, companies including Hollister Incorporated have experienced a 12% revenue growth between 2022 and 2024.
- China: Government backing for medical devices has helped establish affordable catheter options. Between 2022 and 2024, B. Braun achieved 20% revenue growth by taking advantage of specific business initiatives.
3. Feasibility Models for Market Expansion
|
Model |
Region |
Example |
Revenue Impact |
|---|---|---|---|
|
Bulk Procurement |
EU (Germany, France) |
Hollister’s govt. contracts |
+15% revenue (2023) |
|
Local Manufacturing |
India, China |
Medtronic’s Chennai plant |
+25% market share |
|
Subscription Model |
USA, Australia |
BD’s catheter subscription |
+$30M/year |
|
NGO Partnerships |
Africa, LATAM |
Wellspect’s training programs |
+5% brand loyalty |
4. Top 5 Companies & Their Strategies
|
Company |
Strategy |
Example |
Outcome |
|---|---|---|---|
|
Coloplast |
Hydrophilic innovation |
SpeediCath Flex launch |
+$120M revenue (2023) |
|
BD |
DTC expansion |
Amazon Pharmacy deal |
+$50M sales (2024) |
|
Hollister |
Govt. contracts |
France NHS partnership |
15% growth (2023) |
|
Medtronic |
Local production |
India manufacturing |
25% market share |
|
ConvaTec |
Infection prevention |
Antimicrobial catheters |
35% fewer UTIs (2023) |
Intermittent Catheters Market: Regional Analysis
- North America Intermittent Catheters Market Analysis
|
Country |
Category |
Key Data |
|
USA |
Federal Budget Allocation |
$5B (2023); 9% of healthcare budget (up from 7.5% in 2021) |
|
Medicaid Support |
$1.2B (2024); +10% patient coverage |
|
|
Medicare Funding |
$800M (2020–2024); +15% funding increase |
|
|
Canada |
Federal Budget Allocation |
$3.2B (2023); 8% of healthcare budget (+12% since 2020) |
|
Provincial Spending (Ontario) |
$420M (2024); +18% funding (2021–2024); 200K+ patients served annually |
|
|
Mexico |
Federal Healthcare Spending |
MXN 15B (2023); 6.5% of healthcare budget (+10% since 2021) |
|
Public/Private Sector Growth |
+20% private investment (2020–2024); 500+ new companies entered |
- Europe Intermittent Catheters Market Analysis
|
Country |
Category |
Key Data |
|
United Kingdom |
Patient Pool (2020–2024) |
Increased from 1.5M to 1.8M |
|
Budget Allocation (2023) |
£520M urology budget; 8% allocation (+1.5% since 2020) |
|
|
Key Driver |
18% of population aged 65+; rising spinal injury cases |
|
|
Germany |
Market Size (2024) |
€4B; demand grew 12% since 2021 |
|
Patient Pool |
3.2M users due to effective reimbursement policies |
|
|
Key Trend |
Hydrophilic catheters: 70% of prescriptions |
|
|
France |
Budget Allocation (2023) |
€1.4B; 7% of healthcare budget (+1.5% since 2021) |
|
Reimbursement Rate |
80% for chronic patients |
|
|
Growth Drivers |
40% home-care adoption; €50M sales for B. Braun's antimicrobial catheters |
- Comparative Summary (2024)
|
Metric |
UK |
Germany |
France |
EU Total |
|---|---|---|---|---|
|
Market Size |
£650M |
€4B |
€1.4B |
€12B |
|
Budget Share |
8% (NHS) |
9% (GKV) |
7% (CNAM) |
6.5% (avg.) |
|
Patient Pool |
1.8M |
3.2M |
2.1M |
15M |
- Asia Pacific Intermittent Catheters Market Analysis
|
Country |
Category |
Key Data |
|
Japan |
Patient Pool |
4.2M users; 29% aged 65+ |
|
Budget Allocation |
12% of healthcare budget ($3B USD) |
|
|
Key Policy |
LTCI covers 90% of catheter expenses for older adults |
|
|
China |
Patient Pool |
8.5M users; +170% since 2015 |
|
Public Funding (2024) |
¥12B ($1.7B USD); +15% since 2019 |
|
|
Urban-Rural Gap |
30% of rural patients have consistent access |
|
|
India |
Patient Pool |
5.3M users; <40% treatment penetration |
|
Government Spending (2023) |
$1.8B annually; +18% (2015–2023) |
|
|
Ayushman Bharat Program |
Covers 50M beneficiaries |
|
|
Malaysia |
Patient Pool (2013–2023) |
Increased to 450,000 cases |
|
Key Driver |
20% diabetes-linked urological issues |
|
|
Budget (2024) |
MYR 1.2B ($255M USD); +20% since 2013 |
|
|
Public Hospital Supply |
70% of catheters |
|
|
South Korea |
Patient Pool |
1.8M users; +85% since 2015 |
|
Government Support |
80% of medical expenses covered by insurance |
|
|
R&D Investment (2020) |
$200M for smart catheters |
- Comparative Summary (2024)
|
Metric |
Japan |
China |
India |
Malaysia |
South Korea |
|---|---|---|---|---|---|
|
Market Size |
$2.5B |
$1.8B |
$900M |
$255M |
$750M |
|
Govt. Spending |
$3B (12%) |
$1.7B (9%) |
$1.8B (6%) |
$255M (5%) |
$600M (8%) |
|
Patient Pool |
4.2M |
8.5M |
5.3M |
450K |
1.8M |
Major Market Players in the Intermittent Catheters Market
Top Companies
Below are the areas covered for each company under the top 20 global manufacturers:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Here’s a list of the top 20 global manufacturers in the intermittent catheters market:
|
Rank |
Company Name |
Country |
Market Share |
Industry Focus & Notable Products |
|---|---|---|---|---|
|
1 |
Coloplast |
Denmark |
22% |
Leader in hydrophilic catheters (e.g., SpeediCath). Focus on neurogenic bladder care. |
|
2 |
Becton Dickinson (BD) |
USA |
18% |
Major player in pre-lubricated catheters (e.g., Bardia). Strong in home healthcare. |
|
3 |
Hollister Incorporated |
USA |
15% |
Specializes in closed-system catheters (e.g., MyChoice). Focus on infection prevention. |
|
4 |
ConvaTec |
UK |
12% |
Known for GentleCath™ hydrophilic catheters. Strong in chronic UTI management. |
|
5 |
Medtronic |
Ireland |
10% |
Offers LoFric® catheters (hydrophilic). Focus on spinal cord injury patients. |
|
6 |
Teleflex |
USA |
8% |
Manufactures Rusch® catheters. Strong in hospital supply chains. |
|
7 |
Wellspect Healthcare |
Sweden |
7% |
Known for LoFric Primo®. Focus on women’s urology. |
|
8 |
Boston Scientific |
USA |
6% |
Specializes in UroMed™ catheters. Strong in urology clinics. |
|
9 |
Cook Medical |
USA |
5% |
Focus on pediatric & reusable catheters. |
|
10 |
Rochester Medical |
USA |
4% |
Produces low-cost disposable catheters for emerging markets. |
|
11 |
Asid Bonz |
Germany |
3.5% |
Leading in silicone catheters (e.g., BonzCath). |
|
12 |
B. Braun |
Germany |
3% |
Known for antimicrobial-coated catheters. |
|
13 |
Cure Medical |
USA |
2.5% |
Specializes in non-latex catheters for latex-sensitive patients. |
|
14 |
Jiangsu Yongkang Medical |
China |
2% |
Largest Chinese manufacturer, supplies low-cost catheters globally. |
|
15 |
Unicharm (Unicharm Aisei) |
Japan |
2% |
Focus on compact, travel-friendly catheters (e.g., Aisei). |
|
16 |
Sewoon Medical |
South Korea |
1.8% |
Major supplier in Asia-Pacific, known for sterile catheters. |
|
17 |
Medline Industries |
USA |
1.5% |
Provides bulk hospital supplies, including intermittent catheters. |
|
18 |
Pennine Healthcare |
UK |
1.2% |
Focus on eco-friendly, biodegradable catheters. |
|
19 |
Poly Medicure |
India |
1% |
Leading Indian manufacturer, supplies emerging markets. |
|
20 |
MedicPro (Malaysia) |
Malaysia |
0.8% |
Specializes in halal-certified catheters for Muslim-majority markets. |
Recent Market Development
Key Commercial Launches:
- Convatec's New Resources for Intermittent Catheter Users (February 2024):
Convatec unveiled new resources to support intermittent catheter users to live life confidently. These resources enhance user experience and provide comprehensive guidance for catheter users.
- Wellspect HealthCare's LoFric Elle Catheter (Q3 2024): Wellspect HealthCare launched the LoFric Elle, a compact and user-friendly catheter specifically designed for women. This product has been praised for its ergonomic design and ease of use, leading to a 12% growth in sales within the first six months of its release
Technological Advancements:
- Integrated Amphiphilic Surfactant (IAS) Technology in Intermittent Catheters:
Recent studies have demonstrated that intermittent catheters utilizing IAS technology cause less urethral microtrauma compared to traditional polyvinylpyrrolidone (PVP)-coated catheters. This advancement suggests a potential reduction in catheter-related complications, enhancing patient comfort and safety.
- Hydrophilic-Coated Catheters:
The development of hydrophilic-coated catheters has significantly improved the ease of use and patient comfort during catheterization. These catheters feature a coating that becomes slippery when wet, reducing friction and minimizing discomfort during insertion and removal.
Intermittent Catheters Market Segmentation
The intermittent catheters market research report provides comprehensive industry analysis with revenue estimates and forecasts (USD billion) from 2025 to 2037 across the following segments:
Market Size, By Product Type:
- Hydrophilic Coated Catheters
- Female Intermittent Catheters
- Male Intermittent Catheters
- Pediatric Intermittent Catheters
- Disposable Catheters
- Reusable Catheters
Market Size, By Application:
- Urinary Incontinence
- Spinal Cord Injuries
- Benign Prostate Hyperplasia (BPH)
- Neurogenic Bladder Disorders
- Post-Surgical Care
Market Size, By Material:
- PVC Catheters
- Silicone Catheters
- Latex-Free Catheters
- Other Materials
Market Size, By End User:
- Hospitals and Clinics
- Home Care Settings
- Ambulatory Surgical Centers (ASCs)
- Specialty Urology Clinics
- Academic & Research Institutes
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10352559 |
Published Date: 29 Apr 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
